Epigallocatechin-3-gallate does not affect the activity of enzymes involved in metabolic activation and cellular excretion of benzo[a]pyrene in human colon carcinoma cells

Toxicology Letters

Volumn 203, Issue 3, 2011, Pages 258-264

  Bothe, Hanno ^a   Gassmann, Kathrin ^a   Götz, Christine ^a   Fritsche, Ellen ^a,b   Abel, Josef ^a   Haarmann Stemmann, Thomas ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Aryl hydrocarbon receptor; Benzo a pyrene; Caco 2; Chemoprevention; Epigallocatechin 3 gallate

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BENZO[A]PYRENE; CYTOCHROME P450; CYTOCHROME P450 1A1; EPIGALLOCATECHIN GALLATE; FISETIN; FLAVONOID; GLUCURONOSYLTRANSFERASE;

ARTICLE; CARCINOMA CELL; CELL STRAIN CACO 2; CIGARETTE SMOKING; COLON CARCINOMA; EXCRETION; HUMAN; HUMAN CELL; METABOLIC ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEA;

BENZO(A)PYRENE; BIOTRANSFORMATION; CACO-2 CELLS; CATECHIN; CYTOCHROME P-450 CYP1A1; FLAVONOIDS; GLUCURONOSYLTRANSFERASE; HUMANS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER;

EID: 79955960722     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.03.026     Document Type: Article

References (51)

1. Abel J., Haarmann-Stemmann T. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem. 2010, 391:1235-1248.
2. Artursson P., Borchardt R.T. Intestinal drug absorption and metabolism in cell cultures: Caco-2 and beyond. Pharm. Res. 1997, 14:1655-1658.
3. Backlund M., Ingelman-Sundberg M. Regulation of aryl hydrocarbon receptor signal transduction by protein tyrosine kinases. Cell Signal. 2005, 17:39-48.
4. Bothe H., Gotz C., Stobbe-Maicherski N., Fritsche E., Abel J., Haarmann-Stemmann T. Luteolin enhances the bioavailability of benzo(a)pyrene in human colon carcinoma cells. Arch. Biochem. Biophys. 2010, 498:111-118.
5. Buesen R., Mock M., Nau H., Seidel A., Jacob J., Lampen A. Human intestinal Caco-2 cells display active transport of benzo[a]pyrene metabolites. Chem. Biol. Interact. 2003, 142:201-221.
6. Cabrera C., Artacho R., Gimenez R. Beneficial effects of green tea-a review. J. Am. Coll. Nutr. 2006, 25:79-99.
7. Ciolino H.P., Daschner P.J., Wang T.T., Yeh G.C. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem. Pharmacol. 1998, 56:197-206.
8. Crozier A., Jaganath I., Clifford M. Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep. 2009, 26:1001-1043.
9. Ebert B., Seidel A., Lampen A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 2005, 26:1754-1763.
10. Ebert B., Seidel A., Lampen A. Phytochemicals induce breast cancer resistance protein in Caco-2 cells and enhance the transport of benzo[a]pyrene-3-sulfate. Toxicol. Sci. 2007, 96:227-236.
11. Farabegoli F., Papi A., Bartolini G., Ostan R., Orlandi M. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line. Phytomedicine 2010, 17:356-362.
12. Ferguson L.R. Natural and human-made mutagens and carcinogens in the human diet. Toxicology 2002, 181-182:79-82.
13. Gupta S., Hastak K., Afaq F., Ahmad N., Mukhtar H. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 2004, 23:2507-2522.
14. Haarmann-Stemmann T., Sendker J., Götz C., Krug N., Bothe H., Fritsche E., Proksch P., Abel J. Regulation of dioxin receptor function by different beta-carboline alkaloids. Arch. Toxicol. 2010, 84:619-629.
15. Hong J., Lambert J.D., Lee S.H., Sinko P.J., Yang C.S. Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem. Biophys. Res. Commun. 2003, 310:222-227.
16. Ioannides C., Lewis D.F. Cytochromes P450 in the bioactivation of chemicals. Curr. Top. Med. Chem. 2004, 4:1767-1788.
17. Jagerstad M., Skog K. Genotoxicity of heat-processed foods. Mutat. Res. 2005, 574:156-172.
18. Jiang T., Glickman B.W., de Boer J.G. Protective effect of green tea against benzo[a]pyrene-induced mutations in the liver of Big Blue transgenic mice. Mutat. Res. 2001, 480-481:147-151.
19. Jung Y.D., Kim M.S., Shin B.A., Chay K.O., Ahn B.W., Liu W., Bucana C.D., Gallick G.E., Ellis L.M. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br. J. Cancer 2001, 84:844-850.
20. Kasai A., Hiramatsu N., Hayakawa K., Yao J., Kitamura M. Blockade of the dioxin pathway by herbal medicine Formula Bupleuri Minor: identification of active entities for suppression of AhR activation. Biol. Pharm. Bull. 2008, 31:838-846.
21. Kasai S., Kikuchi H. The inhibitory mechanisms of the tyrosine kinase inhibitors herbimycin a, genistein, and tyrphostin B48 with regard to the function of the aryl hydrocarbon receptor in Caco-2 cells. Biosci. Biotechnol. Biochem. 2010, 74:36-43.
22. Kitagawa S., Nabekura T., Takahashi T., Nakamura Y., Sakamoto H., Tano H., Hirai M., Tsukahara G. Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol. Pharm. Bull. 2005, 28:2274-2278.
23. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., Lambert G., Mohr S., Yang C.S. Pharmacokinetics of Tea Catechins after Ingestion of Green Tea and (-)-Epigallocatechin-3-gallate by Humans. Cancer Epidemiol. Biomark. Prevent. 2002, 11:1025-1032.
24. Machemer D.E., Tukey R.H. The role of protein kinase C in regulation of TCDD-mediated CYP1A1 gene expression. Toxicol. Sci. 2005, 87:27-37.
25. Mohamed M.E., Tseng T., Frye R.F. Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. Xenobiotica 2010, 40:663-669.
26. Muto S., Fujita K., Yamazaki Y., Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 2001, 479:197-206.
27. Muto S., Yokoi T., Gondo Y., Katsuki M., Shioyama Y., Fujita K., Kamataki T. Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice. Carcinogenesis 1999, 20:421-424.
28. Nagle D.G., Ferreira D., Zhou Y.D. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 2006, 67:1849-1855.
29. Nakagawa K., Okuda S., Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem. 1997, 61:1981-1985.
30. Nakatsuru Y., Wakabayashi K., Fujii-Kuriyama Y., Ishikawa T., Kusama K., Ide F. Dibenzo[A,L]pyrene-induced genotoxic and carcinogenic responses are dramatically suppressed in aryl hydrocarbon receptor-deficient mice. Int. J. Cancer 2004, 112:179-183.
31. Palermo C.M., Hernando J.I., Dertinger S.D., Kende A.S., Gasiewicz T.A. Identification of potential aryl hydrocarbon receptor antagonists in green tea. Chem. Res. Toxicol. 2003, 16:865-872.
32. Palermo C.M., Westlake C.A., Gasiewicz T.A. Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry 2005, 44:5041-5052.
33. Puppala D., Gairola C.G., Swanson H.I. Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation. Carcinogenesis 2006, 28:639-647.
34. Shimizu M., Deguchi A., Hara Y., Moriwaki H., Weinstein I.B. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem. Biophys. Res. Commun. 2005, 334:947-953.
35. Shimizu M., Deguchi A., Lim J.T.E., Moriwaki H., Kopelovich L., Weinstein I.B. (-)-Epigallocatechin gallate and polyphenon e inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin. Cancer Res. 2005, 11:2735-2746.
36. Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., Fujii-Kuriyama Y., Ishikawa T. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:779-782.
37. Sun C.L., Yuan J.M., Koh W.P., Yu M.C. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 2006, 27:1301-1309.
38. Surh Y.J., Kundu J.K., Na H.K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 2008, 74:1526-1539.
39. Suzuki Y., Tsubono Y., Nakaya N., Koizumi Y., Suzuki Y., Shibuya D., Tsuji I. Green tea and the risk of colorectal cancer: pooled analysis of two prospective studies in Japan. J. Epidemiol. 2005, 15:118-124.
40. Takemura H., Nagayoshi H., Matsuda T., Sakakibara H., Morita M., Matsui A., Ohura T., Shimoi K. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells. Toxicology 2010, 274:42-48.
41. Tsubono Y., Nishino Y., Komatsu S., Hsieh C.C., Kanemura S., Tsuji I., Nakatsuka H., Fukao A., Satoh H., Hisamichi S. Green tea and the risk of gastric cancer in Japan. N. Engl. J. Med. 2001, 344:632-636.
42. Weisburger J.H., Chung F.L. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem. Toxicol. 2002, 40:1145-1154.
43. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 2004, 36:838-849.
44. Williams S.N., Shih H., Guenette D.K., Brackney W., Denison M.S., Pickwell G.V., Quattrochi L.C. Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Chem. Biol. Interact. 2000, 128:211-229.
45. Yang G., Shu X.O., Li H., Chow W.H., Ji B.T., Zhang X., Gao Y.T., Zheng W. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol. Biomark. Prevent. 2007, 16:1219-1223.
46. Yin Z., Henry E.C., Gasiewicz T.A. (-)-Epigallocatechin-3-gallate is a novel Hsp90 inhibitor. Biochemistry 2009, 48:336-345.
47. Yoshimura S., Kawano K., Matsumura R., Sugihara N., Furuno K. Inhibitory effect of flavonoids on the efflux of N-acetyl 5-aminosalicylic acid intracellularly formed in Caco-2 cells. J. Biomed. Biotechnol. 2009, 2009:467489.
48. Yueh M.F., Huang Y.H., Hiller A., Chen S., Nguyen N., Tukey R.H. Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J. Biol. Chem. 2003, 278:15001-15006.
49. Zhang S., Qin C., Safe S.H. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ. Health Perspect. 2003, 111:1877-1882.
50. Zhang S., Yang X., Morris M.E. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol. Pharmacol. 2004, 65:1208-1216.
51. Zhou J.G., Henry E.C., Palermo C.M., Dertinger S.D., Gasiewicz T.A. Species-specific transcriptional activity of synthetic flavonoids in guinea pig and mouse cells as a result of differential activation of the aryl hydrocarbon receptor to interact with dioxin-responsive elements. Mol. Pharmacol. 2003, 63:915-924.